Novel lopinavir analogues incorporating non-Aromatic P-1 side chains--synthesis and structure--activity relationships. 2002

Hing L Sham, and Chen Zhao, and Leping Li, and David A Betebenner, and Ayda Saldivar, and Sudthida Vasavanonda, and Dale J Kempf, and Jacob J Plattner, and Daniel W Norbeck
Pharmaceutical Discovery, R47B, Building AP-10, Abbott Laboratories, Abbott Park, IL 60064-6101, USA. hing.l.sham@abbott.com

The HIV protease inhibitor Lopinavir has a pseudosymmetric core unit incorporating benzyl groups at both P-1, P-1' positions. A series of analogues incorporating non-aromatic side chains at the P-1 position were synthesized and the structure-activity relationships explored.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011744 Pyrimidinones Heterocyclic compounds known as 2-pyrimidones (or 2-hydroxypyrimidines) and 4-pyrimidones (or 4-hydroxypyrimidines) with the general formula C4H4N2O. Pyrimidinone,Pyrimidone,Pyrimidones
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D017320 HIV Protease Inhibitors Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. HIV Protease Inhibitor,Inhibitor, HIV Protease,Inhibitors, HIV Protease,Protease Inhibitor, HIV,Protease Inhibitors, HIV
D061466 Lopinavir An HIV protease inhibitor used in a fixed-dose combination with RITONAVIR. It is also an inhibitor of CYTOCHROME P-450 CYP3A. A-157378.0,ABT 378,ABT-378,N-(4-(((2,6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pydrimidineacetamide,A 157378.0,A157378.0,ABT378

Related Publications

Hing L Sham, and Chen Zhao, and Leping Li, and David A Betebenner, and Ayda Saldivar, and Sudthida Vasavanonda, and Dale J Kempf, and Jacob J Plattner, and Daniel W Norbeck
May 2004, Bioorganic & medicinal chemistry letters,
Hing L Sham, and Chen Zhao, and Leping Li, and David A Betebenner, and Ayda Saldivar, and Sudthida Vasavanonda, and Dale J Kempf, and Jacob J Plattner, and Daniel W Norbeck
September 2015, ChemMedChem,
Hing L Sham, and Chen Zhao, and Leping Li, and David A Betebenner, and Ayda Saldivar, and Sudthida Vasavanonda, and Dale J Kempf, and Jacob J Plattner, and Daniel W Norbeck
January 2010, Journal of medicinal chemistry,
Hing L Sham, and Chen Zhao, and Leping Li, and David A Betebenner, and Ayda Saldivar, and Sudthida Vasavanonda, and Dale J Kempf, and Jacob J Plattner, and Daniel W Norbeck
January 2009, Chemistry (Weinheim an der Bergstrasse, Germany),
Hing L Sham, and Chen Zhao, and Leping Li, and David A Betebenner, and Ayda Saldivar, and Sudthida Vasavanonda, and Dale J Kempf, and Jacob J Plattner, and Daniel W Norbeck
August 1998, The Journal of antibiotics,
Hing L Sham, and Chen Zhao, and Leping Li, and David A Betebenner, and Ayda Saldivar, and Sudthida Vasavanonda, and Dale J Kempf, and Jacob J Plattner, and Daniel W Norbeck
January 1997, Journal of medicinal chemistry,
Hing L Sham, and Chen Zhao, and Leping Li, and David A Betebenner, and Ayda Saldivar, and Sudthida Vasavanonda, and Dale J Kempf, and Jacob J Plattner, and Daniel W Norbeck
April 2002, Bioorganic & medicinal chemistry letters,
Hing L Sham, and Chen Zhao, and Leping Li, and David A Betebenner, and Ayda Saldivar, and Sudthida Vasavanonda, and Dale J Kempf, and Jacob J Plattner, and Daniel W Norbeck
March 2010, Journal of agricultural and food chemistry,
Hing L Sham, and Chen Zhao, and Leping Li, and David A Betebenner, and Ayda Saldivar, and Sudthida Vasavanonda, and Dale J Kempf, and Jacob J Plattner, and Daniel W Norbeck
November 1993, Journal of pharmaceutical sciences,
Hing L Sham, and Chen Zhao, and Leping Li, and David A Betebenner, and Ayda Saldivar, and Sudthida Vasavanonda, and Dale J Kempf, and Jacob J Plattner, and Daniel W Norbeck
September 2004, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!